Stocks · Healthcare · Medical - Specialties
STERIS plc STE
$208.54 -0.38% Close, Oct 2, 2026 · NYSE · Market cap $20.32B
High qualityInexpensive vs sectorLow risk
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- At 25.5× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Diluted EPS over the last four quarters was $8.18, up 25.3% year over year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth49Neutral
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 48%
- EPS growth (TTM, YoY)Top 38%
- FCF growth (TTM, YoY)Bottom 41%
- Revenue growth, 3-year CAGRBottom 48%
- Revenue growth accelerationBottom 49%
Quality83Strong
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 17%
- Gross marginBottom 29%
- Operating marginTop 14%
- Cash conversion (OCF / net income)Top 49%
- Accruals (lower is better)Bottom 39%
- Net debt / EBITDA (lower is better)Top 45%
- Interest coverTop 8%
Value91Exceptional
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 14%
- Free-cash-flow yieldTop 20%
- EBITDA / enterprise valueTop 12%
- Sales / enterprise valueTop 44%
- P/E vs own 5-year history (lower is better)Top 6%
Momentum33Weak
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 33%
- 6-month returnBottom 37%
- 1-year return vs S&P 500Bottom 33%
- Distance from 52-week highTop 36%
- Trend checklist (0–4)Bottom 14%
Revisions49Neutral
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 47%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 34%
- Upside to consensus price targetBottom 35%
Stability97Exceptional
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 4%
- Maximum drawdown, 3 yearsTop 3%
- Beta vs S&P 500 (lower is better)Top 12%
- Net debt / EBITDA (lower is better)Top 45%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 8.7% | 8.4% | ↓ |
| EPS growth (YoY) | 27.9% | 25.3% | ↓ |
| Gross margin | 44.1% | 44.4% | ↑ |
| Operating margin | 16.6% | 18.9% | ↑ |
| FCF margin | 16.3% | 15.3% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 8.4% | 8.7% | ↓ | Bottom 48% |
| EPS growth (TTM, YoY) | 25.3% | 27.9% | ↓ | Top 38% |
| Gross margin | 44.4% | 44.1% | ↑ | Bottom 29% |
| Operating margin | 18.9% | 16.6% | ↑ | Top 14% |
| Net margin | 13.3% | 11.6% | ↑ | — |
| Free-cash-flow margin | 15.3% | 16.3% | ↓ | — |
| Return on invested capital | 8.7% | — | Top 17% | |
| Revenue growth, 3-year CAGR | 9.4% | — | Bottom 48% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 1.60×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 0.86×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 18.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 1.22%
- Net buyback yield (TTM)
- 1.55%
- Shareholder yield
- 2.77%
- Share count change, 1 year
- -0.9%
- Share count change, 3-year CAGR
- -0.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +2.1%
- Average 2-day reaction, last 8
- -0.4%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $271.33
- Target vs current price
- +30.1%
- Analysts with a rating
- 14
- Share rating Buy or Strong Buy
- 86%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +4.0% | -0.1% | +2.3% | -1.4% | — |
| May 11, 2026 | -0.7% | -2.7% | +2.2% | +1.2% | +12.2% |
| Feb 4, 2026 | +0.0% | +1.0% | -6.5% | -7.1% | -17.1% |
| Nov 5, 2025 | +5.1% | +0.5% | +10.3% | +7.3% | +9.3% |
| Aug 6, 2025 | +3.5% | -1.2% | +8.9% | +8.3% | +5.8% |
| May 14, 2025 | +5.4% | -1.6% | +8.4% | +4.1% | +5.1% |
| Feb 5, 2025 | -0.4% | +0.7% | +1.8% | +3.7% | +1.3% |
| Nov 6, 2024 | +0.9% | +0.0% | -2.1% | -4.5% | -3.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | $2.59 | $2.49 | +4.0% | $1.50B |
| May 11, 2026 | $2.83 | $2.85 | -0.7% | $1.59B |
| Feb 4, 2026 | $2.53 | $2.53 | +0.0% | $1.50B |
| Nov 5, 2025 | $2.47 | $2.35 | +5.1% | $1.50B |
| Aug 6, 2025 | $2.34 | $2.26 | +3.5% | $1.40B |
| May 14, 2025 | $2.74 | $2.60 | +5.4% | $1.48B |
| Feb 5, 2025 | $2.32 | $2.33 | -0.4% | $1.40B |
| Nov 6, 2024 | $2.14 | $2.12 | +0.9% | $1.33B |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 25.5× | 49.2× | 0th | Top 14% |
| P/E (forward) | 18.6× | — | — | — |
| EV / EBITDA | 12.1× | — | — | Top 12% |
| EV / Sales | 3.63× | — | — | Top 44% |
| Free-cash-flow yield | 4.55% | — | — | Top 20% |
| Earnings yield | 3.92% | — | — | Top 14% |
P/E over the past five years
Range 26.8× – 184.6× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -13.6%
- Earnings per share growth (TTM)
- +25.3%
- Change in P/E multiple
- -19.8%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -0.5%
- 200-day average slope (20 days)
- -2.1%
- Distance from 50-day average
- -6.9%
- Distance from 200-day average
- -8.6%
- RSI (14)
- 35.7
- Relative volume
- 1.02×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 24.3%
- Volatility vs own 5-year history
- 46th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.41
- Correlation with S&P 500
- 0.27
- Current drawdown from 1-year high
- -22.4%
- Maximum drawdown, 3 years
- -25.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 20, 2022 | Sep 27, 2022 | -36.4% | 110 days | 781 days (Nov 6, 2025) |
| Jan 16, 2026 | Jun 17, 2026 | -25.8% | 104 days | Not yet recovered |
| Jan 8, 2021 | Mar 4, 2021 | -15.6% | 37 days | 27 days (Apr 13, 2021) |
| Apr 26, 2021 | Jun 1, 2021 | -13.0% | 25 days | 41 days (Jul 29, 2021) |
| Dec 30, 2021 | Jan 27, 2022 | -12.2% | 19 days | 25 days (Mar 4, 2022) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $20.32B
- P/E (TTM)
- 25.5
- EPS, diluted (TTM)
- $8.18
- Revenue (TTM)
- $6.04B
- Dividend yield
- 1.24%
- 52-week range
- $195.14 – $269.44
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Revenue | $4.22B | $4.54B | $5.14B | $5.46B | $5.94B |
| Gross profit | $1.88B | $1.98B | $2.22B | $2.40B | $2.63B |
| Operating income | $477.8M | $791.1M | $836.1M | $866.6M | $1.10B |
| Net income | $243.9M | $107.0M | $378.2M | $614.6M | $785.1M |
| EPS (diluted) | $2.48 | $1.07 | $3.81 | $6.20 | $7.93 |
| Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.37B | $1.48B | $1.39B | $1.46B | $1.50B | $1.59B | $1.49B |
| Net income | $150.0M | $173.5M | $145.7M | $177.4M | $191.9M | $192.8M | $220.3M | $200.1M |
| EPS (diluted) | $1.51 | $1.75 | $1.48 | $1.79 | $1.94 | $1.96 | $2.24 | $2.04 |
| FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|
| Operating cash flow | $684.8M | $756.9M | $973.3M | $1.15B | $1.34B |
| Capital expenditure | -$287.6M | -$362.0M | -$360.3M | -$370.1M | -$369.0M |
| Free cash flow | $397.2M | $395.0M | $612.9M | $778.0M | $972.4M |
| Dividends paid | -$163.2M | -$183.5M | -$200.6M | -$219.9M | -$241.8M |
| Net share buybacks | -$55.8M | -$308.6M | -$11.8M | -$211.3M | -$202.6M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $482.3M
- Total assets
- $10.74B
- Total liabilities
- $3.51B
- Total debt
- $2.04B
- Net debt
- $1.56B
- Shareholders’ equity
- $7.21B
As of Jun 30, 2026 (filed Aug 7, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Sep 4, 2026 | $0.69 | Sep 25, 2026 |
| Jun 8, 2026 | $0.63 | Jun 26, 2026 |
| Feb 17, 2026 | $0.63 | Mar 19, 2026 |
| Nov 18, 2025 | $0.63 | Dec 18, 2025 |
| Sep 4, 2025 | $0.63 | Sep 26, 2025 |
| Jun 10, 2025 | $0.57 | Jun 26, 2025 |
| Feb 20, 2025 | $0.57 | Mar 21, 2025 |
| Nov 19, 2024 | $0.57 | Dec 19, 2024 |
Short interest
- Shares sold short
- 2,788,451
- Days to cover
- 4.58
- Change vs previous report
- +14.1%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Aug 25, 1998
- 2-for-1
- Aug 25, 1995
- 2-for-1